Atlas Trials

Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects

Clinical trial NCT03027960 · COMPLETED

Trial details

NCT number
NCT03027960
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Heart FailureType II; Diabetes
Start date
2017-06-27
Primary completion
2019-05-14
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.